Peters on Diabetes
Anne Peters, MD, Director, Clinical Diabetes Programs; Professor, Keck School of Medicine, University of Southern California, Los Angeles, California- What Should We Tell Patients About the Insulin Glargine (LantusĀ®) Controversy?
- On the RECORD: Rosiglitazone Safer Than Previously Thought
- Using Hemoglobin A1c Values to Diagnose Diabetes
- Tips for Initiating Insulin Therapy for Type 2 Diabetes
- Should We Raise Glucose Targets in the ICU?
- Treating Diabetes During the Economic Crunch
- Updated ADA Guidelines for Treating Type 2 Diabetes
- World Diabetes Day 2008
- The Results of the Long-Awaited UK Prospective Diabetes Study (UKPDS)
- The Benefits of Continuous Glucose Monitoring
- Diabetes Prevention and Ralph DeFronzo
- Understanding the ACCORD, ADVANCE, and VA Trials
- Metformin Guidelines
- Insulin Pump Safety